Literature DB >> 8998494

Quality of life in gastric cancer prior to gastrectomy.

J Svedlund1, M Sullivan, I Sjödin, B Liedman, L Lundell.   

Abstract

A growing number of surgical trials include quality of life variables in the overall assessment of outcomes. This is believed to broaden the criteria for choice of treatment and the evaluation of treatment regimens. The present study is a baseline evaluation of the health-related quality of life in patients with gastric cancer facing surgery. The quality of life in these patients was related to that of other patient groups referred for surgical interventions and general population groups. Our study included 103 consecutive patients with carcinoma of the stomach considered amenable to a curative major surgical procedure. The quality of life evaluation was based on a battery of questionnaires, covering general body symptoms, mood level and functional limitations. Patients with gastric cancer reported more neurasthenic complaints such as reduced sexual interest, insomnia and poor appetite as well as a lower mood level than the general population. The gastric cancer group also showed a markedly lower mood level in comparison with a group of cancer survivors 2-3 years after diagnosis and patients with intermittent claudication. The mental well-being of gastric cancer patients matched that of cancer survivors with one or more recurrences. Overall, 25% of the gastric cancer patients reported functional limitations regarded as clinically significant. Patients with intermittent claudication reported more and patients with small cell lung cancer markedly more limitations. We conclude that although patients with gastric cancer showed a low level of limitations on average, problems in the areas of sleep/rest, home management and, especially, eating were frequently reported.

Entities:  

Mesh:

Year:  1996        PMID: 8998494     DOI: 10.1007/bf00434747

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

Review 1.  Standards for validating health measures: definition and content.

Authors:  J E Ware
Journal:  J Chronic Dis       Date:  1987

2.  Mood and somatic symptoms.

Authors:  L O Persson; L Sjöberg
Journal:  J Psychosom Res       Date:  1987       Impact factor: 3.006

3.  A controlled randomized study of early cardiac rehabilitation: the Sickness Impact Profile as an assessment tool.

Authors:  C R Ott; E S Sivarajan; K M Newton; M J Almes; R A Bruce; M Bergner; B S Gilson
Journal:  Heart Lung       Date:  1983-03       Impact factor: 2.210

4.  Psychotherapy in peptic ulcer disease. A controlled outcome study.

Authors:  I Sjödin
Journal:  Acta Psychiatr Scand Suppl       Date:  1983

5.  Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.

Authors:  C Bombardier; J Ware; I J Russell; M Larson; A Chalmers; J L Read
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

6.  The functional status of ESRD patients as measured by the Sickness Impact Profile.

Authors:  L G Hart; R W Evans
Journal:  J Chronic Dis       Date:  1987

7.  Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

Authors:  M A Testa; R B Anderson; J F Nackley; N K Hollenberg
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

8.  Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study.

Authors:  M Sullivan; M Ahlmén; B Archenholtz; G Svensson
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

9.  Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.

Authors:  B Bergman; M Sullivan; S Sörenson
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

10.  Quality of life and functional results following different types of resection for gastric carcinoma.

Authors:  K Buhl; P Schlag; C Herfarth
Journal:  Eur J Surg Oncol       Date:  1990-08       Impact factor: 4.424

View more
  3 in total

Review 1.  Quality of life in gastric cancer.

Authors:  Ad-A Kaptein; Satoshi Morita; Junichi Sakamoto
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

2.  Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial.

Authors:  S Kostic; A Kjellin; M Ruth; H Lönroth; E Johnsson; M Andersson; L Lundell
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

3.  Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy.

Authors:  S Kostic; E Johnsson; A Kjellin; M Ruth; H Lönroth; M Andersson; L Lundell
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.